Levodopa

左旋多巴

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameLevodopa
Drug Alias NameLevodopum左多巴左旋多巴胺InbrijaPOD™ levodopa +[13] 
ClassificationSmall molecules
Mechanisms of ActionDopamine receptors agonists
TargetsDopamine receptors
Therapy Area/IndicationsIschemic StrokeStress Disorders, Post-TraumaticAutism Spectrum Disorder +[9] 
Global Approved IndicationsParkinson DiseaseParkinsonian Disorders
Approved Indications in ChinaParkinson Disease
Original Approved Country/TerritoryUnited States
Original Approved Date1970/06/04
Country/TerritoryCzechiaBelgiumBulgaria +[28] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityMerz Therapeutics GmbHPureIMS BV +[12] 
Inactive CompaniesSingapore University Of Technology And DesignAcorda TherapeuticsWashington University School Of Medicine +[4] 
Active IndicationsStress Disorders, Post-TraumaticAutism Spectrum DisorderDiabetic Retinopathy +[6] 
Inactive IndicationsIschemic StrokeDyskinesiasTourette Syndrome

Other Information

ATC CodeN04BA01
Related LinksWikipediaDrugBankKEGG